Latest News
For years, Yale School of Medicine's Kasia Lipska, MD, MHS, has been advocating for affordable pricing of insulin, an essential —and sometimes lifesaving—drug for many individuals with diabetes. Now, she is turning her attention to a similar trend of soaring prices among new diabetes and obesity medications.
- April 15, 2024
As a part of our “Meet Yale Internal Medicine” series, today’s feature is on Sachin Majumdar Jr., MD, associate professor of medicine (endocrinology); and director of endocrine neoplasia and the endocrine neoplasia clinic.
- April 10, 2024
In a Q&A, Gerald I. Shulman, MD, PhD, George R. Cowgill Professor of Medicine (Endocrinology) and professor of cellular and molecular physiology, discusses the basics of insulin resistance, how the condition impacts our health, and the steps we can take to reverse it.
- March 20, 2024
In a Q&A, Mireille Serlie, MD, PhD, discusses the effects of eating patterns on the brain, the risks of being frequently exposed to high-sucrose and high-fat foods, and recommendations for adopting healthy eating habits.
- February 05, 2024
In a Q&A, Ania Jastreboff, MD, PhD, discusses the barriers to treating obesity, benefits of clinical trials, and the new era of obesity medicine.
- January 18, 2024
Hemoglobin A1c (HbA1c) level plays an important role in type 2 diabetes (T2D) treatment, serving as an important indicator of an individual’s glucose control. The Endocrine Society has outlined specific HbA1c target ranges for older adults (above 65 years of age), based on their individual health status as being either in good, intermediate, or poor health.